Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2008-7-28
pubmed:abstractText
Helper-dependent adenoviral vectors (HDAd) can mediate long-term phenotypic correction in the ornithine transacarbamylase (OTC)-deficient mice model with negligible chronic toxicity. However, the high doses required for metabolic correction will result in systemic inflammatory response syndrome in humans. This acute toxicity represents the major obstacle for clinical applications of HDAd vectors for the treatment of OTC deficiency. Strategies for reducing the dose necessary for disease correction are highly desirable because HDAd acute toxicity is clearly dose-dependent.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-10064660, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-10759467, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-11148551, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-11356076, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-11779420, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-11987790, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-12490001, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-1281456, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-14512318, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-14567964, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-14599819, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-14965376, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-15336649, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-15451463, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-15466081, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-15963925, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-16000063, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-16154372, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-16677864, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-16871229, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-17285138, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-17538087, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-17979676, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-6717540, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-8631974, http://linkedlifedata.com/resource/pubmed/commentcorrection/18563850-9686349
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1521-2254
pubmed:author
pubmed:copyrightInfo
(c) 2008 John Wiley & Sons, Ltd.
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
890-6
pubmed:dateRevised
2011-8-1
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors.
pubmed:affiliation
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural